Jaguar health announces closing of bridge financing priced at-the-market under nasdaq rules

San francisco, california / access newswire / april 1, 2025 / jaguar health, inc. ( nasdaq:jagx ) ("jaguar" or "the company"), today announced the closing of its previously announced private placement. jaguar's president and chief executive officer lisa conte, as well as other members of the company's board of directors and other c-suite and senior executives of jaguar along with selected institutional and accredited investors (each, an "investor") entered into securities purchase agreements in connection with this private placement, pursuant to which the company issued approximately $3.448 million aggregate principal amount of convertible promissory notes (collectively, the "notes") to such investors in a private placement priced at-the-market under nasdaq rules.
NDAQ Ratings Summary
NDAQ Quant Ranking